New Drugs Helping AD Catch Up to Psoriasis
H.L. Greenberg, MD
PeerAddressing the Unique Challenges of AD Patients
Patrick Burnett, MD, PhD, FAAD
PeerFDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
Alexandra Golant, MD, FAAD
Peer